Companies developing high-quality biosimilar GLP-1 therapies with competitive pricing and proven bioequivalence will democratize access while capturing significant market share in cost-sensitive segments
Giunchi, V., Fusaroli, M., Hauben, M., Raschi, E., & Poluzzi, E
They have just slid down the pecking order for reasons about to become obvious
In fact, I was recently interviewed by CBC News (check me out on the radio and print article) to discuss this very topic and answer one of the questions I hear most often from clients: Can I naturally increase my GLP-1 without taking medication? The short answer is yesbut with an important caveat
Osteoclast number on the surface of trabecular bone was observed by histological analysis, which demonstrated a significant decrease after 16 weeks of exendin-4 use in OVX rats (10)